Immunocore Hldgs (NASDAQ:IMCR)报告季度每股亏损$(0.47)，低于分析师一致预期的$(0.24)，差距为95.83%。与去年同期每股亏损$(0.40)相比，这一数据减少了17.5%。公司报告季度销售额为$84.05M，高于分析师一致预期的$83.55M，增幅为0.60%。与去年同期销售额$70.16M相比，这一数据增长了19.80%。

以上内容来自Benzinga Earnings专栏，原文如下：

Immunocore Hldgs (NASDAQ:IMCR) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.24) by 95.83 percent. This is a 17.5 percent decrease over losses of $(0.40) per share from the same period last year. The company reported quarterly sales of $84.05 million which beat the analyst consensus estimate of $83.55 million by 0.60 percent. This is a 19.80 percent increase over sales of $70.16 million the same period last year.